Christoph Correll
Psychiatry · Glen Oaks, NYNPI 1053475954
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 18.2%. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 740 payments — averaging $2093.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- H. Lundbeck A S$282K
- Teva Pharmaceuticals USA, Inc.$234K
- Alkermes, Inc.$155K
- Boehringer Ingelheim$128K
- Mylan Inc.$103K
- Sumitomo Pharma Co., Ltd.$64K
- plus $584K from 34 others
Across 44 payments — averaging $16,390 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$402K
- Takeda$225K
- Janssen Research & Development, LLC$72K
- Teva Pharmaceuticals USA, Inc.$17K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
- Neurocrine Biosciences, Inc.$1K
- plus $465 from 1 others
What the payments were for
- Consulting fees$799,52552%
- Speaking & faculty fees$453,02429%
- Travel & lodging$278,58118%
- Food & beverage$15,3791%
- Education$2,4360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$237,013
- ARISTADA$178,231
- ABILIFY MAINTENA$170,434
- REXULTI$83,463
- LATUDA$49,613
- UZEDY$46,550
- BRINTELLIX$41,320
- INVEGA TRINZA$39,543
- INVEGA SUSTENNA$39,520
- CAPLYTA$38,480
- ARISTADA INITIO$36,518
- LOT$25,164
- 63402-304-07$24,188
- ZOLOFT$21,935
- VRAYLAR$17,645
- NUPLAZID$15,388
- INGREZZA$13,599
- COBENFY$13,036
- INVEGA$13,022
- EFFEXOR$9,149
How this compares
$1,548,946 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Glen Oaks
- John KaneGlen Oaks$817K
- Youssef HassounGlen Oaks$233K
- Jose Rubio-LorenteGlen Oaks$106K
- Delbert RobinsonGlen Oaks$83K
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.